Due to NLS-mutant ITSN1-S (cytoplasmic ITSN1-S) led to lower migration and invasion capacity than control, it suggested that ITSN1-S in the cytoplasm could inhibit breast cancer cells migration and invasion (Fig. 7A–C and Supplementary Fig. S2A, B). Here, ITSN1 is linked to breast carcinoma.